1-20 of 20
Marwan Kwok
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impaired Response to Oxidative DNA Damage Underlies Genomic Instability in B-Cell Leukemia Driven By RPS15 Mutation

Marwan Kwok, Catherine Gutierrez, Neil Ruthen, Peyton Waddicor, Tamara Ouspenskaia, Christina Curran, Doris Fu, Binyamin Knisbacher, Anat Biran, Adi Nagler, Aviv Liani, Sarah Chen, Gregory Lazarian, Elizabeth Witten, Gabriela Brunsting Hoffmann, Emma Lin, Lucas Pomerance, Shuqiang Li, Lili Wang, Kenneth J. Livak, Donna S. Neuberg, Gad Getz, Elisa Ten Hacken, Catherine J. Wu
Journal: Blood
Blood (2024) 144 (Supplement 1): 758.
https://doi.org/10.1182/blood-2024-202115
Published: 2024
Journal Articles

Leukemia Evolution and Resistance to Graft-Versus-Leukemia Responses Revealed By Mitochondrial DNA Mutations

Livius Penter, Nicoletta Cieri, Katie Maurer, Marwan Kwok, Haoxiang Lyu, Wesley S Lu, Giacomo Oliveira, Satyen H Gohil, Ignaty Leshchiner, Caleb Lareau, Leif S Ludwig, Donna S. Neuberg, Haesook T. Kim, Shuqiang Li, Lars Bullinger, Jerome Ritz, Gad Getz, Jacqueline S. Garcia, Robert J. Soiffer, Kenneth J. Livak, Catherine J. Wu
Journal: Blood
Blood (2024) 144 (Supplement 1): 926.
https://doi.org/10.1182/blood-2024-199009
Published: 2024
Journal Articles

Targeting therapeutic vulnerabilities in T-PLL

Marwan Kwok, Tatjana Stankovic
Journal: Blood
Blood (2024) 144 (15): 1548–1550.
https://doi.org/10.1182/blood.2024025596
Published: 2024
Journal Articles

DNA damage response defects in hematologic malignancies: mechanistic insights and therapeutic strategies

Marwan Kwok, Angelo Agathanggelou, Tatjana Stankovic
Journal: Blood
Blood (2024) 143 (21): 2123–2144.
https://doi.org/10.1182/blood.2023019963
Published: 2024
Journal Articles

CLL patients: GIVe me three!

Clinical Trials & Observations
Marwan Kwok, Tatjana Stankovic
Journal: Blood
Blood (2023) 142 (11): 941–943.
https://doi.org/10.1182/blood.2023021284
Published: 2023
Journal Articles

Linking epigenome regulation with DNA repair

Tatjana Stankovic, Marwan Kwok
Journal: Blood
Blood (2022) 139 (23): 3356–3357.
https://doi.org/10.1182/blood.2022016176
Published: 2022
Journal Articles

The three musketeers: uniting against CLL

Marwan Kwok, Tatjana Stankovic
Journal: Blood
Blood (2022) 139 (9): 1264–1265.
https://doi.org/10.1182/blood.2021014826
Published: 2022
Journal Articles

Ibrutinib: another string to its bow

Clinical Trials & Observations
Tatjana Stankovic, Marwan Kwok
Journal: Blood
Blood (2021) 137 (25): 3461–3462.
https://doi.org/10.1182/blood.2021011574
Published: 2021
Journal Articles

Genetics in the era of targeted CLL therapy

Tatjana Stankovic, Marwan Kwok
Journal: Blood
Blood (2020) 135 (26): 2333–2334.
https://doi.org/10.1182/blood.2020005595
Published: 2020
Journal Articles

Integrative analysis of spontaneous CLL regression highlights genetic and microenvironmental interdependency in CLL

Clinical Trials & Observations
Marwan Kwok, Ceri Oldreive, Andy C. Rawstron, Anshita Goel, Grigorios Papatzikas, Rhiannon E. Jones, Samantha Drennan, Angelo Agathanggelou, Archana Sharma-Oates, Paul Evans, Edward Smith, Surita Dalal, Jingwen Mao, Robert Hollows, Naheema Gordon, Mayumi Hamada, Nicholas J. Davies, Helen Parry, Andrew D. Beggs, Talha Munir, Paul Moreton, Shankara Paneesha, Guy Pratt, A. Malcolm R. Taylor, Francesco Forconi, Duncan M. Baird, Jean-Baptiste Cazier, Paul Moss, Peter Hillmen, Tatjana Stankovic
Journal: Blood
Blood (2020) 135 (6): 411–428.
https://doi.org/10.1182/blood.2019001262
Published: 2020
Includes: Supplemental data
Journal Articles

BCR Unresponsiveness and 13q14 Duplication Underpin Spontaneous Disease Regression in Chronic Lymphocytic Leukemia

Marwan Kwok, MBBS,MRCP, Andy Rawstron, PhD, Angelo Agathanggelou, PhD, Anshita Goel, PhD, Ceri Oldreive, PhD, Rhiannon E Jones, PhD, Samantha Drennan, PhD, Archana Sharma-Oates, PhD, Paul Evans, PhD, Edward Smith, MSc, Jingwen Mao, Jamie Beaumont, Jusveen Rai, Mayumi Hamada, MB ChB, Surita Dalal, PhD, Naheema Gordon, MSc, Nicholas Davies, PhD, Helen Parry, MB ChB, MRCP, PhD, Andrew Beggs, MBBS, PhD FRCS, Talha Munir, Paul Moreton, MD MRCP, FRCPath, Shankara Paneesha, MD MRCP, FRCPath, Guy Pratt, MD FRCP, FRCPath, Malcolm Taylor, PhD, Francesco Forconi, MD DM, PhD FRCPath, Duncan M Baird, PhD, Jean-Baptiste Cazier, PhD, Paul Moss, MBBS, PhD FRCP, Peter Hillmen, MBChB, PhD, Tatjana Stankovic, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3004.
https://doi.org/10.1182/blood.V130.Suppl_1.3004.3004
Published: 2017
Journal Articles

USP7 inhibition alters homologous recombination repair and targets CLL cells independently of ATM/p53 functional status

Angelo Agathanggelou, Edward Smith, Nicholas J. Davies, Marwan Kwok, Anastasia Zlatanou, Ceri E. Oldreive, Jingwen Mao, David Da Costa, Sina Yadollahi, Tracey Perry, Pamela Kearns, Anna Skowronska, Elliot Yates, Helen Parry, Peter Hillmen, Celine Reverdy, Remi Delansorne, Shankara Paneesha, Guy Pratt, Paul Moss, A. Malcolm R. Taylor, Grant S. Stewart, Tatjana Stankovic
Journal: Blood
Blood (2017) 130 (2): 156–166.
https://doi.org/10.1182/blood-2016-12-758219
Published: 2017
Includes: Supplemental data
Journal Articles

Minimal residual disease is an independent predictor for 10-year survival in CLL

Clinical Trials & Observations Brief Report
Marwan Kwok, Andy C. Rawstron, Abraham Varghese, Paul A. S. Evans, Sheila J. M. O’Connor, Chi Doughty, Darren J. Newton, Paul Moreton, Peter Hillmen
Journal: Blood
Blood (2016) 128 (24): 2770–2773.
https://doi.org/10.1182/blood-2016-05-714162
Published: 2016
Includes: Supplemental data
Journal Articles

ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53 - or ATM -defective chronic lymphocytic leukemia cells

Marwan Kwok, Nicholas Davies, Angelo Agathanggelou, Edward Smith, Ceri Oldreive, Eva Petermann, Grant Stewart, Jeff Brown, Alan Lau, Guy Pratt, Helen Parry, Malcolm Taylor, Paul Moss, Peter Hillmen, Tatjana Stankovic
Journal: Blood
Blood (2016) 127 (5): 582–595.
https://doi.org/10.1182/blood-2015-05-644872
Published: 2016
Includes: Supplemental data
Journal Articles

Kinetics of CLL Subclonal Architecture: Spontaneous Disease Progression or Treatment-Induced Selection?

Ceri Oldreive, Nick Davies, PhD, Anna Skowronska, PhD, Marwan Kwok, MB ChB, MRCP, Guy Pratt, MDPhD, Paul Moss, Michael John Griffiths, BSc, Samuel Clokie, A. Malcolm R Taylor, Tatjana Stankovic
Journal: Blood
Blood (2015) 126 (23): 167.
https://doi.org/10.1182/blood.V126.23.167.167
Published: 2015
Journal Articles

CLL Progression Is Associated with Increased Clonal Diversity and Replication Stress

Angelo Agathanggelou, PhD, Anna Skowronska, PhD, Nick Davies, PhD, Marwan Kwok, MB ChB, MRCP, Samuel Clockie, Mike Griffiths, Alexander Taylor, Tatjana Stankovic, MD PhD
Journal: Blood
Blood (2014) 124 (21): 1977.
https://doi.org/10.1182/blood.V124.21.1977.1977
Published: 2014
Journal Articles

ATR Inhibition Exacerbates Replication Stress in TP53 or ATM Deficient CLL Cells and Enhances Sensitivity to Chemotherapy and Targeted Therapy

Marwan Kwok, MB ChB, MRCP, Nicholas Davies, PhD, Angelo Agathanggelou, PhD, Edward Smith, BSc, Eva Petermann, PhD, Eliot Yates, BMedSc, Jeffrey Brown, PhD, Alan Lau, PhD, Tatjana Stankovic, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3340.
https://doi.org/10.1182/blood.V124.21.3340.3340
Published: 2014
Journal Articles

Synthetic Lethality In CLL With DNA Damage Response Defect By Targeting ATR Pathway

Tatjana Stankovic, MD, PhD, Davies Nicholas, Marwan Kwok, Edward Smith, Eliot Yates, Angelo Agathanggelou, Brown Jeff, Alan Lau
Journal: Blood
Blood (2013) 122 (21): 120.
https://doi.org/10.1182/blood.V122.21.120.120
Published: 2013
Journal Articles

Minimal Residual Disease Is a Predictor for Progression-Free and Overall Survival in Chronic Lymphocytic Leukemia (CLL) That Is Independent of the Type or Line of Therapy.

Marwan Kwok, MB, ChB, Andy C. Rawstron, PhD, Abraham Varghese, MB, ChB, MRCP, Peter Hillmen, MB, ChB, PhD
Journal: Blood
Blood (2009) 114 (22): 540.
https://doi.org/10.1182/blood.V114.22.540.540
Published: 2009
Journal Articles

Monoclonal B-Cell Lymphocytosis (MBL) Is a Precursor State for Chronic Lymphocytic Leukemia (CLL) with 1% Progression Per Year.

Andy C. Rawstron, Fiona L. Bennet, Sheila J.M. O’Connor, Marwan Kwok, James A.L. Fenton, Marieth Plummer, Ruth M. de Tute, Roger G. Owen, Stephen J. Richards, Andrew S. Jack, Peter Hillmen
Journal: Blood
Blood (2007) 110 (11): 749.
https://doi.org/10.1182/blood.V110.11.749.749
Published: 2007